BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
search help

Documents 1-18 out of 18 found
  Current Search:  uvadex: 24, methoxsalen: 97  

100%
TEXT
http://www.fda.gov/cder/orange/appendix_a.txt
4, ACETAMINOPHEN TYLENOL W/ CODEINE, ACETAMINOPHEN TYLENOL, ACETAMINOPHEN (OTC) TYLOX, ACETAMINOPHEN TYLOX-325, ACETAMINOPHEN TYMTRAN, CERULETIDE DIETHYLAMINE TYZINE, TETRAHYDROZOLINE HYDROCHLORIDE TZ-3, TIOCONAZOLE (OTC) ** U ** U-CORT, HYDROCORTISONE ACETATE U-GENCIN, GENTAMICIN SULFATE UCEPHAN, SODIUM BENZOATE ULO, CHLOPHEDIANOL HYDROCHLORIDE ULTANE, SEVOFLURANE ULTIVA,...

Matching: uvadex methoxsalen Find similar documents More document info
100%
HTML
FDA Drug Approvals List- February 1999
Applicant: CONNETICS CORP Active Ingredient(s): BETAMETHASONE VALERATE OTC/RX Status: RX Indication(s):For the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses of the scalp Original Application #: 020969 Approval Date: 25-FEB-99 Trade Name: UVADEX Chemical Type: 3 Therapeutic Potential: S Dosage Form: SOLUTION Applicant: THERAKOS...
Matching: uvadex methoxsalen Find similar documents More document info
100%
PDF
20969LTR.PDF
UVADEX ® (Methoxsalen) STERILE SOLUTION, 20 mcg/ mL Uvadex O (methoxsalen) Sterile Solution should be used only by physicians who have special competence in the diagnosis and treatment of cutaneous T- cell lymphoma and who have special training and experience in the UVAR ® Photopheresis System
The chemical name of methoxsalen is 9- methoxy-...

author: Unknown
Matching: uvadex methoxsalen Find similar documents More document info

100%
PDF
20969LTR.PDF page 10


author: Unknown
Matching: uvadex methoxsalen Find similar documents More document info

100%
PDF
20969LTR.PDF page 9


author: Unknown
Matching: uvadex methoxsalen Find similar documents More document info

100%
PDF
20969LTR.PDF page 8


author: Unknown
Matching: uvadex methoxsalen Find similar documents More document info

100%
PDF
20969LTR.PDF page 7


author: Unknown
Matching: uvadex methoxsalen Find similar documents More document info

100%
PDF
20969LTR.PDF page 6


author: Unknown
Matching: uvadex methoxsalen Find similar documents More document info

100%
PDF
20969LTR.PDF page 5


author: Unknown
Matching: uvadex methoxsalen Find similar documents More document info

100%
PDF
20969LTR.PDF page 4


author: Unknown
Matching: uvadex methoxsalen Find similar documents More document info

100%
PDF
20969LTR.PDF page 3


author: Unknown
Matching: uvadex methoxsalen Find similar documents More document info

100%
PDF
20969LTR.PDF page 2


author: Unknown
Matching: uvadex methoxsalen Find similar documents More document info

100%
PDF
20969LTR.PDF page 1


author: Unknown
Matching: uvadex methoxsalen Find similar documents More document info

100%
PDF
20969LTR.PDF
NDA 20- 969 THERAKOS, Inc
Schwartz: Please refer to your new drug application (NDA) dated February 20, 1998, received February 25, 1998, and submitted under section 505( b) of the Federal Food, Drug, and Cosmetic Act for UVADEX ® (methoxsalen) Sterile Solution, 20 mcg/ mL
We acknowledge receipt of your submissions dated March 19 and 26; April 16, 17, and 29;...

author: Unknown
Matching: uvadex methoxsalen Find similar documents More document info

100%
PDF
20969LTR.PDF page 1


author: Unknown
Matching: uvadex methoxsalen Find similar documents More document info

53%
HTML
Premarket Approval Decisions September 1999
FDA Home Page | CDRH Home Page | Search | CDRH A-Z Index | Contact CDRH PMA Final Decisions Rendered for September 1999 Some of the documents on this section of the CDRH Website are available only in PDF format and may not be accessible to those with certain disabilities
P990004 9/30/99 SURGIFOAM Absorbable Gelatin Sponge, U.S.P
P820003/S074 9/1/99 Model 5388 External Pulse...
author: OSM/DID
Matching: uvadex Find similar documents More document info
53%
HTML
Premarket Approval Decisions for March 2000
FDA Home Page | CDRH Home Page | Search | CDRH A-Z Index | Contact CDRH PMA Final Decisions Rendered for March 2000 Some of the documents on this section of the CDRH Website are available only in PDF format and may not be accessible to those with certain disabilities
HAZELWOOD, MO 63042 APPROVAL FOR THE ADDITION OF THE ANTIBIOTIC NALIDIXIC ACID AT CONCETRATIONS OF 8, 16, AND 32UG...
author: OSM/DID
Matching: uvadex Find similar documents More document info
53%
PDF
Quark.PDF page 13


author: default
Matching: uvadex Find similar documents More document info


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.